143 related articles for article (PubMed ID: 27384883)
1. Functional characterization of the 12p12.1 renal cancer-susceptibility locus implicates BHLHE41.
Bigot P; Colli LM; Machiela MJ; Jessop L; Myers TA; Carrouget J; Wagner S; Roberson D; Eymerit C; Henrion D; Chanock SJ
Nat Commun; 2016 Jul; 7():12098. PubMed ID: 27384883
[TBL] [Abstract][Full Text] [Related]
2. Multiple renal cancer susceptibility polymorphisms modulate the HIF pathway.
Grampp S; Schmid V; Salama R; Lauer V; Kranz F; Platt JL; Smythies J; Choudhry H; Goppelt-Struebe M; Ratcliffe PJ; Mole DR; Schödel J
PLoS Genet; 2017 Jul; 13(7):e1006872. PubMed ID: 28715484
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of BHLHE41, correlated with DNA hypomethylation in 3'UTR region, promotes the growth of human clear cell renal cell carcinoma.
Shen Z; Zhu L; Zhang C; Cui X; Lu J
Oncol Rep; 2019 Apr; 41(4):2137-2147. PubMed ID: 30816499
[TBL] [Abstract][Full Text] [Related]
4. Altered regulation of DPF3, a member of the SWI/SNF complexes, underlies the 14q24 renal cancer susceptibility locus.
Colli LM; Jessop L; Myers TA; Camp SY; Machiela MJ; Choi J; Cunha R; Onabajo O; Mills GC; Schmid V; Brodie SA; Delattre O; Mole DR; Purdue MP; Yu K; Brown KM; Chanock SJ
Am J Hum Genet; 2021 Sep; 108(9):1590-1610. PubMed ID: 34390653
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism rs4787951 in IL-4R contributes to the increased risk of renal cell carcinoma in a Chinese population.
Lin Y; Yuan Q; Qian F; Qin C; Cao Q; Wang M; Chu H; Zhang Z
Gene; 2019 Feb; 685():242-247. PubMed ID: 30472377
[TBL] [Abstract][Full Text] [Related]
6. The chromosome 2p21 region harbors a complex genetic architecture for association with risk for renal cell carcinoma.
Han SS; Yeager M; Moore LE; Wei MH; Pfeiffer R; Toure O; Purdue MP; Johansson M; Scelo G; Chung CC; Gaborieau V; Zaridze D; Schwartz K; Szeszenia-Dabrowska N; Davis F; Bencko V; Colt JS; Janout V; Matveev V; Foretova L; Mates D; Navratilova M; Boffetta P; Berg CD; Grubb RL; Stevens VL; Thun MJ; Diver WR; Gapstur SM; Albanes D; Weinstein SJ; Virtamo J; Burdett L; Brisuda A; McKay JD; Fraumeni JF; Chatterjee N; Rosenberg PS; Rothman N; Brennan P; Chow WH; Tucker MA; Chanock SJ; Toro JR
Hum Mol Genet; 2012 Mar; 21(5):1190-200. PubMed ID: 22113997
[TBL] [Abstract][Full Text] [Related]
7. Potential Susceptibility Loci Identified for Renal Cell Carcinoma by Targeting Obesity-Related Genes.
Shu X; Purdue MP; Ye Y; Tu H; Wood CG; Tannir NM; Wang Z; Albanes D; Gapstur SM; Stevens VL; Rothman N; Chanock SJ; Wu X
Cancer Epidemiol Biomarkers Prev; 2017 Sep; 26(9):1436-1442. PubMed ID: 28626070
[No Abstract] [Full Text] [Related]
8. Functional analysis of the 11q23.3 glioma susceptibility locus implicates PHLDB1 and DDX6 in glioma susceptibility.
Baskin R; Woods NT; Mendoza-Fandiño G; Forsyth P; Egan KM; Monteiro AN
Sci Rep; 2015 Nov; 5():17367. PubMed ID: 26610392
[TBL] [Abstract][Full Text] [Related]
9. A common variant at 8q24.21 is associated with renal cell cancer.
Gudmundsson J; Sulem P; Gudbjartsson DF; Masson G; Petursdottir V; Hardarson S; Gudjonsson SA; Johannsdottir H; Helgadottir HT; Stacey SN; Magnusson OT; Helgason H; Panadero A; van der Zanden LF; Aben KK; Vermeulen SH; Oosterwijk E; Kong A; Mayordomo JI; Sverrisdottir A; Jonsson E; Gudbjartsson T; Einarsson GV; Kiemeney LA; Thorsteinsdottir U; Rafnar T; Stefansson K
Nat Commun; 2013; 4():2776. PubMed ID: 24220699
[TBL] [Abstract][Full Text] [Related]
10. Chromosome 11q13.3 variant modifies renal cell cancer risk in a Chinese population.
Cao Q; Qin C; Ju X; Meng X; Wang M; Zhu J; Li P; Chen J; Zhang Z; Yin C
Mutagenesis; 2012 May; 27(3):345-50. PubMed ID: 22131124
[TBL] [Abstract][Full Text] [Related]
11. Common variation at 1q24.1 (ALDH9A1) is a potential risk factor for renal cancer.
Henrion MY; Purdue MP; Scelo G; Broderick P; Frampton M; Ritchie A; Meade A; Li P; McKay J; Johansson M; Lathrop M; Larkin J; Rothman N; Wang Z; Chow WH; Stevens VL; Diver WR; Albanes D; Virtamo J; Brennan P; Eisen T; Chanock S; Houlston RS
PLoS One; 2015; 10(3):e0122589. PubMed ID: 25826619
[TBL] [Abstract][Full Text] [Related]
12. Disease-related growth factor and embryonic signaling pathways modulate an enhancer of TCF21 expression at the 6q23.2 coronary heart disease locus.
Miller CL; Anderson DR; Kundu RK; Raiesdana A; Nürnberg ST; Diaz R; Cheng K; Leeper NJ; Chen CH; Chang IS; Schadt EE; Hsiung CA; Assimes TL; Quertermous T
PLoS Genet; 2013; 9(7):e1003652. PubMed ID: 23874238
[TBL] [Abstract][Full Text] [Related]
13. The protein tyrosine phosphatase receptor type J is regulated by the pVHL-HIF axis in clear cell renal cell carcinoma.
Casagrande S; Ruf M; Rechsteiner M; Morra L; Brun-Schmid S; von Teichman A; Krek W; Schraml P; Moch H
J Pathol; 2013 Mar; 229(4):525-34. PubMed ID: 23007793
[TBL] [Abstract][Full Text] [Related]
14. Genetic alterations in renal cell carcinoma with rhabdoid differentiation.
Perrino CM; Hucthagowder V; Evenson M; Kulkarni S; Humphrey PA
Hum Pathol; 2015 Jan; 46(1):9-16. PubMed ID: 25439741
[TBL] [Abstract][Full Text] [Related]
15. Protective C allele of the single-nucleotide polymorphism rs1335532 is associated with strong binding of Ascl2 transcription factor and elevated CD58 expression in B-cells.
Mitkin NA; Muratova AM; Korneev KV; Pavshintsev VV; Rumyantsev KA; Vagida MS; Uvarova AN; Afanasyeva MA; Schwartz AM; Kuprash DV
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3211-3220. PubMed ID: 30006149
[TBL] [Abstract][Full Text] [Related]
16. A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23.
Wu X; Scelo G; Purdue MP; Rothman N; Johansson M; Ye Y; Wang Z; Zelenika D; Moore LE; Wood CG; Prokhortchouk E; Gaborieau V; Jacobs KB; Chow WH; Toro JR; Zaridze D; Lin J; Lubinski J; Trubicka J; Szeszenia-Dabrowska N; Lissowska J; Rudnai P; Fabianova E; Mates D; Jinga V; Bencko V; Slamova A; Holcatova I; Navratilova M; Janout V; Boffetta P; Colt JS; Davis FG; Schwartz KL; Banks RE; Selby PJ; Harnden P; Berg CD; Hsing AW; Grubb RL; Boeing H; Vineis P; Clavel-Chapelon F; Palli D; Tumino R; Krogh V; Panico S; Duell EJ; Quirós JR; Sanchez MJ; Navarro C; Ardanaz E; Dorronsoro M; Khaw KT; Allen NE; Bueno-de-Mesquita HB; Peeters PH; Trichopoulos D; Linseisen J; Ljungberg B; Overvad K; Tjønneland A; Romieu I; Riboli E; Stevens VL; Thun MJ; Diver WR; Gapstur SM; Pharoah PD; Easton DF; Albanes D; Virtamo J; Vatten L; Hveem K; Fletcher T; Koppova K; Cussenot O; Cancel-Tassin G; Benhamou S; Hildebrandt MA; Pu X; Foglio M; Lechner D; Hutchinson A; Yeager M; Fraumeni JF; Lathrop M; Skryabin KG; McKay JD; Gu J; Brennan P; Chanock SJ
Hum Mol Genet; 2012 Jan; 21(2):456-62. PubMed ID: 22010048
[TBL] [Abstract][Full Text] [Related]
17. Functional Analysis of a Novel Genome-Wide Association Study Signal in SMAD3 That Confers Protection From Coronary Artery Disease.
Turner AW; Martinuk A; Silva A; Lau P; Nikpay M; Eriksson P; Folkersen L; Perisic L; Hedin U; Soubeyrand S; McPherson R
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):972-83. PubMed ID: 26966274
[TBL] [Abstract][Full Text] [Related]
18. Mutation analysis of hypoxia-inducible factors HIF1A and HIF2A in renal cell carcinoma.
Morris MR; Hughes DJ; Tian YM; Ricketts CJ; Lau KW; Gentle D; Shuib S; Serrano-Fernandez P; Lubinski J; Wiesener MS; Pugh CW; Latif F; Ratcliffe PJ; Maher ER
Anticancer Res; 2009 Nov; 29(11):4337-43. PubMed ID: 20032376
[TBL] [Abstract][Full Text] [Related]
19. Loss of VHL and hypoxia provokes PAX2 up-regulation in clear cell renal cell carcinoma.
Luu VD; Boysen G; Struckmann K; Casagrande S; von Teichman A; Wild PJ; Sulser T; Schraml P; Moch H
Clin Cancer Res; 2009 May; 15(10):3297-304. PubMed ID: 19401348
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of RICTOR gene transcription by the proinflammatory cytokines through NF-κB pathway contributes to the metastasis of renal cell carcinoma.
Sun B; Chen L; Fu H; Guo L; Guo H; Zhang N
Tumour Biol; 2016 Apr; 37(4):4457-66. PubMed ID: 26500094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
